Table S1.
Drugs screened for the effect on BRD4 hyperphosphorylation
Name | Target | Effect on BRD4 hyperphosphorylation |
Ibrutinib | BTK | No effect |
Idelalisib | PI3K (p110δ) | No effect |
Trametinib | MEK1/2 | No effect |
TBB | CKII | No effect |
LDC000067 | CDK9 | Inhibits BRD4 hyperphosphorylation in HCC2429 |
PHA767491 | CDK9/CDC7 | Inhibits BRD4 hyperphosphorylation in HCC2429 |
Flavopiridol | CDKs | Inhibits BRD4 hyperphosphorylation in HCC2429 |
DRB | CDK9 and many other kinases | Inhibits BRD4 hyperphosphorylation in HCC2429 |
Apigenin | CDK9 and many other kinases | Inhibits BRD4 hyperphosphorylation in HCC2429 |
Wortmannin | PI3K/ATM | No effect |
Danusertib | Aurora A/B/C | No effect |
Sotrastaurin | pan-PKC | No effect |
MK-2206 | Akt1/2/3 | No effect |
KU-55933 | ATM | No effect |
D4476 | CKI | No effect |
CHIR99021 | GSK-3α/β | No effect |
SRPIN340 | SRPK1 | No effect |
NU7441 | DNA-PK | No effect |
Palbociclib | CDK4/6 | No effect |
3-Deazaneplanocin A (DZNep) | EZH2 | No effect |
BIX01294 | G9a | No effect |
GSK343 | EZH2 | No effect |
CPI-169 | EZH2 | No effect |
C646 | p300 | Inhibits BRD4 hyperphosphorylation in HCC2429 |
(+)-JQ1 | BRD4 and other BET proteins | Reduces BRD4 hyperphosphorylation in HCC2429 |
HMBA | Releases P-TEFb, induces HEXIM1, also targets p300 and BRD4 | Reduces BRD4 hyperphosphorylation in HCC2429 |